Research and analysis

TFMS: Behavioural paper supporting the consensus statement on mass testing, 27 August 2020

Updated 29 April 2022

Multidisciplinary Task and Finish Group on Mass Testing.

1. Effective mass testing for population case detection of SARS-CoV-2 will require high rates of testing and self-isolation (more than 90%) [footnote 1] [footnote 2], achieved equitably in any targeted population. Outlined below are key elements of any mass testing programme that could go some way towards achieving this.

Engagement

2. High levels of engagement in health-related research and interventions is built on trust, shared goals, and perceived fairness [footnote 3] [footnote 4] [footnote 5]. Trust in those running services may be particularly important for engagement in government test and track systems [footnote 6], with perceived credibility of government associated with likelihood of self-isolating [footnote 7]. High levels of engagement also require bridging cultural and language barriers to achieve engagement across diverse communities [footnote 4] [footnote 8]. The key principles for achieving this include co-design with target communities of interventions and messages, and promotion of collective identities. [footnote 9]

3. Messages that engage communities and individuals in any testing programme will include the rationale for testing, individual and collective benefits and responsibilities (including reassurance for those concerned about posing an infection risk to family and others) and addressing privacy concerns [footnote 4] [footnote 7] [footnote 10]. It will also be important to specify the financial and other support that will enable self-isolation without incurring hardship (see Self-isolation and quarantine below). These messages, delivered using multiple media in multiple languages and formats, require evaluation to ensure they do communicate the intended messages effectively and equitably. The importance of these and other principles was highlighted in Leicester, where the NHS Test and Trace system faced major challenges in effectively engaging culturally diverse communities [footnote 8].

Testing rates

4. A rapid review of evidence identified several barriers to symptom reporting during an outbreak of infectious disease, including lack of knowledge; concerns about stigmatization, privacy and financial consequences of infection; low concern about symptoms; and difficulties of attending a healthcare facility [footnote 11]. It should be noted that this evidence is limited, based on cross-sectional designs with self-reported behavioural outcomes.

5. Amongst those who report symptoms consistent with COVID-19 in England, around 10% report requesting a test through the NHS Test and Trace system [footnote 12]. The Office for National Statistics (ONS) estimated 2,400 new cases per day in England on 21 August 2020. The rolling average of new cases through Pillar 1 and Pillar 2 NHS Test, trace and Isolate (TTI) was around 800. This is largely (though not exclusively) symptomatic testing but suggests an upper rate of about 30% of those with symptoms requesting testing.

6. These low rates likely reflect many of the barriers to symptom reporting identified by Carter 2020. For example, the percentage of people who know that the symptoms of COVID-19 include cough and fever has remained steady at around 60% since April 2020 [footnote 12]. As PCD does not require people to have knowledge of what symptoms are relevant or to engage in a process of determining whether their own symptoms indicate the need for a test, uptake might be higher, all other things being equal.

7. There is a large literature on increasing uptake rates of screening and other population level interventions including vaccinations [footnote 13] [footnote 14] [footnote 15] [footnote 16] [footnote 17] [footnote 18]. This includes a smaller literature on how to increase uptake equitably, that is to achieve uptake rates that are similarly high regardless of indices of deprivation [footnote 19] [footnote 20]. How any test is offered is a major predictor of uptake rates. 2 considerations are particularly relevant to mass testing:

  • accessibility of testing
  • access provided by testing

i. Accessibility of testing

Testing rates are higher when tests are provided at multiple points for easily accessible testing with low friction. For example, walk-in centres requiring no completion of forms, conducted by health-care workers providing information and some support [footnote 21] [footnote 22]. Self-administered tests conducted at home with rapid results and without need for a lab offer potentially high accessibility, but this will depend upon test distribution, effective communication about testing and its consequences and an accredited system for recording of results [footnote 23].

ii. Access provided by testing

Requiring testing as a pre-condition of entry to a workplace, health or social care establishment, school, university campus or indoor event leads to high rates of testing [footnote 24]. Such requirements may also discourage some with impacts on equity unknown.

Self-isolation and quarantine

8. Rates of quarantine following an infectious disease outbreak vary between 0% and 92.8% [footnote 25]. Adherence is associated with knowledge of the disease and quarantine procedures, perceived risk of infection and provision of material and financial support [footnote 25] [footnote 26] [footnote 27].

9. Around 20% of those reporting symptoms of COVID-19 in England report fully self-isolating by staying at home [footnote 26]. Rates of self-isolation from other members of a household is likely to be lower due to physical and other practical constraints [footnote 28]. These rates may be even lower in those who are asymptomatic who receive a test positive result on mass testing given likely lower perceived risk of being infected.

10. Self-reported ability to self-isolate or quarantine is 3 times lower in those with incomes less than £20,000 or savings less than £100 [footnote 23]. Willingness to self-isolate is similarly high across all income and wealth groups. These findings are echoed in accounts during the current pandemic of those in low paid employment unable to self-isolate for financial reasons [footnote 29] [footnote 30].

11. Based on observational evidence, provision of structural support seems highly likely to increase rates of self-isolation and quarantine although the effect size of each type of support, singly or together is unknown [footnote 25] [footnote 26] [footnote 31]. This will require financial and other resources at levels that hitherto have not been made available in England as part of the existing NHS Test and Trace system. While paid sick leave has been judged an effective intervention to reduce transmission of SARS-CoV-2 across Organisation for Economic Co-operation and Development countries (OECD), it does not include all workers such as those on casual or zero-hour contracts or gig workers [footnote 32]. In addition, payment level and duration vary considerably across countries with the level most often below gross pay.

12. Provision of financial support to safeguard incomes would likely have the single largest effect in achieving equitable testing. Making it so testing that benefits the social groups with fewest material and other resources, as well as those with the most. This is based on descriptive analyses of COVID-19 and other pandemics and epidemics which clearly highlight the difficulties for those who are poorest to support themselves and their families without leaving their homes [footnote 33] [footnote 34] [footnote 35] [footnote 36] [footnote 37] [footnote 38]. It also includes a study conducted in the current pandemic in which intentions to self-isolate in a general population sample in Israel increased from 57% to 94% when lost wages were to be compensated [footnote 37].

13. Below are 4 components of structured support highlighted in the literature cited above.

i. Provide information, social and clinical support proactively with daily contact using SMS or telephone offered, as part of supportive accountability [footnote 38]. Coordinated provision of such support would need to be established for each programme of mass testing.

  • information provided needs to include a clear rationale for self-isolation or quarantine including its effectiveness and the protocol to be followed
  • social and clinical support might include connecting to local schemes for social support such as COVID-19 health champions in Newham, London [footnote 39] or schemes set up for specific communities targeted for mass testing such as universities

ii. Ensure sufficient supplies of food, other essential goods, as well as support for chores or duties outside the home.

iii. Ensure employment protection for those needing to self-isolate or quarantine, including parents who may need to stay at home with a quarantined child. For example, following mass testing in schools.

  • Scotland has issued a fair work statement to guide employers and employees including ensuring: “No worker should be financially penalised for following medical advice” [footnote 40]

iv. Provide financial assistance for those financially affected by isolation or quarantine so they have no drop in weekly income.

  • such assistance would need to be rapid and easy to obtain
  • amongst those in the UK entitled to statutory sick pay, this is frequently reported as insufficient both in amount and duration for many of the lowest paid to meet the basic expenses of daily living
  • in Scotland, recent changes to the Public Health (Scotland) Act 2008 entitles people to financial compensation if they are subject to any loss having been specifically instructed to quarantine or restrict their work-related activities by public health officials [footnote 41]

Enforcement

14. Without enforcement, some people behave sub-optimally during a pandemic, and indeed at other times [footnote 24]. Without enforcement, some objective measures of mobility showed small increases over time during lockdown in the UK and elsewhere [footnote 42] [footnote 43] [footnote 44] self-reports of staying at home decreased [footnote 45], and self-reports of complete compliance with Government guidelines also decreased [footnote 46]. Methods of enforcement include fines for violation, with and without electronic monitoring, denying entry to public spaces without electronically validated proof of being virus-free, and mandating self-isolation and quarantining in supervised facilities [footnote 31] [footnote 47]. The acceptability of these different methods varies across countries, with harsher measures more likely to be applied in authoritarian regimes and contexts, with harsher measures more acceptable as a condition upon entry or re-entry to a country, than for those living in the country.

15. There is an absence of evidence regarding the effectiveness of any of these methods of other than presumed high effectiveness of mandated methods described above. The relative balance between providing support for self-isolation and enforcement is also unknown.

16. Evaluation of systems of enforcement deemed fair in the UK is warranted for mass testing programmes predicated on high rates of self-isolation and quarantine.

Impacts to be anticipated

i. Detecting higher rates of infection

Mass population testing will detect higher rates of infection than current symptom-based testing [footnote 48] [footnote 49]. Depending on test performance some of those identified as infected will not be infected (false positives). The number asked to self-isolate could be reduced by follow-up diagnostic testing.

Some employers and employees do not want to be self-isolating so are resistant to mass testing, as noted in internal memos regarding responses in Leicester in July 2020. Mitigation might require intervention by government agencies such as the Health and Safety Executive as well as government interventions, at local and national level, to ensure no loss of income to employees and to secure employment in those required to self-isolate or quarantine. It should be noted, however, that this will could lead to significant loss of income to some employers particularly small and medium-sized enterprises (SMEs).

Organisations participating in mass testing should anticipate this. For example, schools and universities need to plan teaching for those self-isolating or quarantined.

ii. Detecting higher rates of non-infection

Mass population testing will result in more people being informed that they are currently not infected than is currently the case in the UK given most testing is restricted to those who are symptomatic.

We are unaware of any evidence regarding the behavioural impact of receiving test-negative results from symptomatic or asymptomatic testing for SARS-CoV-2. Such a result has the potential to decrease behaviours to reduce risk of transmission if it is misunderstood as indicating a status that extends beyond the time of testing. It might, for example, delay seeking testing if symptoms appear after a test-negative result. If it is misunderstood to reflect no risk of infection it could reduce other risk-reducing behaviours such as hand hygiene [footnote 50].

iii. Impact on NHS Test and Trace symptomatic testing

Tests used for mass population testing particularly in low prevalence settings and populations will result in higher false positives than symptomatic testing using lab-based PCR tests, resulting in more people misclassified as infected who are not. This may undermine public confidence in all testing.

This might be mitigated by effective communications of the aims of the different testing programmes, mass testing compared to symptomatic testing, and the meaning of test results from each. More generally, public understanding of testing and test results requires additional work. Many more people believe that they have already had COVID-19 than current data support, a belief that is associated with a perception of immunity to COVID-19 and reduced intention to engage in social distancing measures [footnote 12]. Mass testing, and a high rate of false positive results, may exacerbate this, necessitating development and evaluation of interventions for pre-emption.

iv. Marginalisation and stigmatisation of communities

Mass population testing will likely reveal higher rates of infection in areas of high deprivation where many in BAME groups reside. This has the potential to fuel existing racial tensions but also the potential to provide welcomed support depending on whether and how tensions are anticipated and testing is implemented [footnote 51] [footnote 52]. Mitigation measures include engaging local community leaders in co-production of guidance and communications explaining the rationale for mass testing and how community members can support each other [footnote 52].

v. Other possible impacts

Given limited experience in the UK with mass testing requiring self-isolation and quarantine at scale, it would be prudent to set up systems to detect and manage unexpected consequences as they arise. This might comprise surveys and interviews with both those delivering and those to whom any testing is targeted.

References

  1. Kucharski AJ, Klepac P, Conlan AJK, et al. Effectiveness of isolation, testing, contact tracing, and physical distancing on reducing transmission of SARS-CoV-2 in different settings: a mathematical modelling study [published online ahead of print, 2020 Jun 15]. Lancet Infect Dis. 2020;S1473-3099(20)30457-6. doi:10.1016/S1473-3099(20)30457-6. 

  2. Grassly NC, Pons-Salort M, Parker EP, White PJ, Ferguson NM, Ainslie K, Baguelin M, Bhatt S, Boonyasiri A, Brazeau N, Cattarino L. Comparison of molecular testing strategies for COVID-19 control: a mathematical modelling study. The Lancet Infectious Diseases. 18 August 2020. 

  3. Bargain O, Aminjonov U. Trust and Compliance to Public Health Policies in Times of COVID-19

  4. SPI-B. Public Health Messaging for Communities from Different Cultural Backgrounds, presented to SAGE on 23 July 2020.  2 3

  5. Reicher S, Stott C. On order and disorder during the COVID‐19 pandemic. British Journal of Social Psychology. 2020 July;59(3):694-702. 

  6. Devine D, Gaskell J, Jennings W, Stoker G Trust and Behavioural Responses to COVID-19

  7. Smith LE, Fear NT, Potts HWW, Michie S, Amlot R, Rubin GJ. Factors associated with requesting an antigen test and self-isolating after developing symptoms of coronavirus. Report to DHSC. 2020a July 17.  2

  8. Nazareth J, Minhas JS, Jenkins DR, Sahota A, Khunti K, Haldar P, Pareek M. Early lessons from a second COVID-19 lockdown in Leicester, UK. The Lancet. 2020 Jul 18;396(10245):e4-5.  2

  9. Bonell C, Michie S, Reicher S, West R, Bear L, Yardley L, Curtis V, Amlôt R, Rubin GJ. Harnessing behavioural science in public health campaigns to maintain ‘social distancing’ in response to the COVID-19 pandemic: key principles. J Epidemiol Community Health. 2020 May 8. 

  10. Eckert S, Sopory P, Day A, et al. Health-Related Disaster Communication and Social Media: Mixed-Method Systematic Review. ‘Health Commun’ 2018; 33(12): 1389-400. 

  11. Carter P, Megnin-Viggars O, Rubin GJ. What factors influence symptom reporting during an emerging infectious disease outbreak? A rapid review of the evidence. medRxiv. July 23 2020. www.medrxiv.org/content/10.1101/2020.07.23.20159897v1.article-info 

  12. Smith LE, Mottershaw AL, Egan M, Waller J, Marteau TM, Rubin GJ. The impact of believing you have had COVID-19 on behaviour: Cross-sectional survey. medRxiv. 2020. www.medrxiv.org/content/10.1101/2020.04.30.20086223v1  2 3

  13. Jepson R, Clegg A, Forbes C, Lewis R, Sowden A, Kleijnen J. The determinants of screening uptake and interventions for increasing uptake: a systematic review. In Database of Abstracts of Reviews of Effects (DARE): Quality-assessed Reviews [Internet] 2000. Centre for Reviews and Dissemination (UK). 

  14. Mandrik O, Tolma E, Zielonke N, Meheus F, Ordóñez-Reyes C, Severens JL, Murillo R. Systematic reviews as a ‘lens of evidence’: Determinants of participation in breast cancer screening. Journal of Medical Screening. 9 June 2020:0969141320930743. 

  15. Tsipa A, O’Connor DB, Branley-Bell D, Day F, Hall LH, Sykes-Muskett B, Wilding S, Taylor N, Conner M. Promoting colorectal cancer screening: a systematic review and meta-analysis of randomised controlled trials of interventions to increase uptake. Health Psychology Review. 2020 May 13:1-24. 

  16. Chapman GB, Li M, Colby H, Yoon H. Opting in vs opting out of influenza vaccination. JAMA. 2010;304(1):43-44. doi:10.1001/jama.2010.892 

  17. Henriquez-Camacho C, Villafuerte-Gutierrez P, Pérez-Molina JA, Losa J, Gotuzzo E, Cheyne N. Opt-out screening strategy for HIV infection among patients attending emergency departments: systematic review and meta-analysis. HIV Med. 2017;18(6):419-429. doi:10.1111/hiv.12474 

  18. Mohammed H, McMillan M, Roberts CT, Marshall HS. A systematic review of interventions to improve uptake of pertussis vaccination in pregnancy. PloS one. 2019 Mar 28;14(3):e0214538. 

  19. Mackie A. 2017 Screening inequalities and what we’re doing about them

  20. Crocker-Buque T, Edelstein M, Mounier-Jack S. Interventions to reduce inequalities in vaccine uptake in children and adolescents aged< 19 years: a systematic review. J Epidemiol Community Health. 1 January 2017;71(1):87-97. 

  21. Kim E. Comparing the Operational Strategies of South Korea and Israel’s Coronavirus Drive-Through Testing Centers and the Implications on Testing Capacity. Risk Management and Healthcare Policy. 2020;13:821. 

  22. Kim SI, Lee JY. Walk-Through screening center for COVID-19: an accessible and efficient screening system in a pandemic situation. Journal of Korean Medical Science. 20 April 2020;35(15). 

  23. Atchison CJ, Bowman L, Vrinten C, Redd R, Pristera P, Eaton JW, Ward H. Perceptions and behavioural responses of the general public during the COVID-19 pandemic: A cross-sectional survey of UK Adults. medRxiv. 1 January 2020. www.medrxiv.org/content/10.1101/2020.04.01.20050039v1  2

  24. Erev, I., Plonsky, O. & Roth, Y. Complacency, panic, and the value of gentle rule enforcement in addressing pandemics. ‘Nat Hum Behav’ (2020). https://doi.org/10.1038/s41562-020-00939-z  2

  25. Webster RK, Brooks SK, Smith LE, Woodland L, Wessely S, Rubin GJ. How to improve adherence with quarantine: Rapid review of the evidence. Public Health. 30 March 2020.  2 3

  26. Smith LE, Amlôt R, Lambert H, Oliver I, Robin C, Yardley L, Rubin GJ. Factors associated with adherence to self-isolation and lockdown measures in the UK; a cross-sectional survey. medRxiv. 2020 www.medrxiv.org/content/10.1101/2020.06.01.20119040v1 Public Health (in press).  2 3

  27. Denford S, Morton KS, Horwood J, de Garang R, Yardley L. Preventing within household transmission of COVID-19: Is self-isolation outside the home feasible and acceptable?www.medrxiv.org/content/10.1101/2020.08.20.20176529v1 

  28. Wallis G, Siracusa F, Blank M, Painter H, Sanchez J, Salinas K, Mamuyac C, Marudamuthu C, Wrigley F, Corrah T, Rampling T. Experience of a novel community testing programme for COVID-19 in London: Lessons learnt. Clinical Medicine. 17 July 2020. 

  29. BBC News. Coronavirus: ‘Big problem’ at Leicester factories, say workers. 7 July 2020. 

  30. UNISON. Care worker pay deductions must be tackled to stop hardship and control virus spread. 15 June 2020. 

  31. Wang CJ, Ng CY, Brook RH. Response to COVID-19 in Taiwan: big data analytics, new technology, and proactive testing. Jama. 14 April 2020;323(14):1341-2.  2

  32. Thewissen S, MacDonald D, Prinz C, Stricot M. The critical role of paid sick leave in the COVID-19 health and labour market crisis. VoxEU.org. 8 July 2020. 

  33. Rothstein, Mark A., and Meghan K. Talbott. ‘Encouraging compliance with quarantine: a proposal to provide job security and income replacement.’ ‘American journal of public health’ 97.Supplement 1 (2007): S49-S56. 

  34. Blake, Kelly D., Robert J. Blendon, and Kasisomayajula Viswanath. ‘Employment and compliance with pandemic influenza mitigation recommendations.’ ‘Emerging infectious diseases’ 16, no. 2 (2010): 212. 

  35. Kavanagh, Anne M., et al. ‘Leave entitlements, time off work and the household financial impacts of quarantine compliance during an H1N1 outbreak.’ ‘BMC infectious diseases’ 12.1 (2012): 311. 

  36. Kumar, Supriya, Sandra Crouse Quinn, Kevin H. Kim, Laura H. Daniel, and Vicki S. Freimuth. ‘The impact of workplace policies and other social factors on self-reported influenza-like illness incidence during the 2009 H1N1 pandemic.’ ‘American Journal of Public Health’ 102, no. 1 (2012): 134-140. 

  37. Bodas M, Peleg K. Self-Isolation Compliance In The COVID-19 Era Influenced By Compensation: Findings From A Recent Survey In Israel: Public attitudes toward the COVID-19 outbreak and self-isolation: a cross sectional study of the adult population of Israel. Health Affairs. 1 June 2020;39(6):936-41.  2

  38. Mohr D, Cuijpers P, Lehman K. Supportive accountability: a model for providing human support to enhance adherence to eHealth interventions. Journal of medical Internet research. 2011;13(1):e30.  2

  39. Newham COVID-19 Health Champions

  40. Scottish Government. Coronavirus (COVID-19): fair work statement

  41. Public Health etc. (Scotland) Act 2008 

  42. Georganas S. Mobile data shows which European countries took lockdown seriously. The Conversation. 

  43. Apple Mobility Data 

  44. Ritchie H. Google mobility trends: How has the pandemic changed the movement of people around the world? 

  45. SPI-B. Consensus on Reintroduction of Measures and their Impact on Rate of Infection. Figure 2. June 2020. 

  46. Fancourt D, Bu F, Wan Mak H, Steptoe A. COVID-19 Social Study. Results Release 18. 

  47. Scarpetti G, Webb E, Hernandez-Quevedo C. How do measures for isolation, quarantine, and contact tracing differ among countries? a cross-country analysis. 2020. Accessed 18 August 2020. 

  48. Dattner I, Goldberg Y, Katriel G, Yaari R, Gal N, Miron Y, Ziv A, Hamo Y, Huppert A. The role of children in the spread of COVID-19: Using household data from Bnei Brak, Israel, to estimate the relative susceptibility and infectivity of children. medRxiv. 1 January 2020. 

  49. Yoon Y, Kim KR, Park H, young Kim S, Kim YJ. Stepwise School Opening Online and Off-line and an Impact on the Epidemiology of COVID-19 in the Pediatric Population. medRxiv. 1 January 2020. 

  50. Waller J, Rubin GJ, Potts HW, Mottershaw A, Marteau TM. Immunity Passports for SARS-CoV-2: an online experimental study of the impact of antibody test terminology on perceived risk and behaviour. medRxiv. www.medrxiv.org/content/10.1101/2020.05.06.20093401v1 2020 BMJ Open (in press). 

  51. Commission for Countering Extremism. ‘COVID-19: How hateful extremists are exploiting the pandemic’, 2020. 

  52. SPI-B. Consensus Statement on Local Interventions. Presented to SAGE 30 July 2020.  2